JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
LONG® R3 IGF-I is an analog of IGF-1 that was developed for use in mammalian serum free cell culture to promote cell growth, survival, and recombinant protein expression. When supplemented in serum-free medium, it promotes cell proliferation, increases cell survival, and enhances productivity through better proliferative and anti-apoptotic signaling. It has an increased half-life in vitro and in vivo and a low affinity for IGF binding proteins (IGFBP) that make it ideal for both research and large-scale culturing.
The protein was created by substituting an arginine (R) for glutamic acid (E) at amino acid 3 and extending the N-terminal end of the peptide by 13 amino acids (MFPAMPLSSLFVN). All cell types that have a growth response to insulin in cell culture have the potential to respond to LONG® R3 IGF-I.
Recombinant Human LONG® R3 IGF-I is a single, non-glycosylated polypeptide chain containing 83 amino acids.